Ian Ingram

Deputy Managing Editor
MedPage Today

[ASCO @ASCO]

.@rschilsky Bids Adieu to ASCO — As chief medical officer, he made oncologist group into an important research engine. By @icingram via @medpagetoday https://t.co/nYOR1bBYSM

[MedPage Today @medpagetoday]

Trump Bans Travel From Europe https://t.co/n05FOlov8j

[Ian Ingram @icingram]

Excellent piece.

[MedPage Today @medpagetoday]

"The next thing he knew, he was face down in the water, disoriented -- numb. He couldn't move his arms or legs. He needed to breathe but couldn't." By @hlavinka_e. @mwetschler
https://t.co/stkm3boOai

[Ian Ingram @icingram]

@cardiac_fitness @medpagetoday Can you expand on the safety of exercise a bit, say for cancer patients with known CVD. What kind of activities are recommended?

[Ian Ingram @icingram]

@medpagetoday Hi everyone, this is Ian Ingram, deputy managing editor at MedPage Today here #cardiooncoconnect

[Ian Ingram @icingram]

@CaPsurvivorship @DrGuptaD Are there data on some of CV risks with some of these newer agents? Any particular group of patients that are best not treated with these based on the FDA labels or signals from the trials?

[MedPage Oncology @MedpageOnco]

New combinations with immune checkpoint inhibitors have toppled the former standard in metastatic #RCC and sparked a debate over which clinicians should gravitate toward, and for whom. #kidneycancer #kcsm @DrChoueiri @kai_tsao @NEJM
https://t.co/gK2yvfciYH